Bovine mastitis is a global concern that incurs huge economic losses to the global agriculture sector. Mastitis results in lowered milk production in affected animals and causes continuous veterinary expenses, resulting in reduced profitability for dairy farmers. According to the estimates published by Thermo Fisher Scientific in July 2022, the total annual cost to the global dairy industry caused by mastitis is between US$ 19.7 billion to US$ 32 billion.
According to the study “Global and countrywide prevalence of subclinical and clinical mastitis in dairy cattle and buffaloes by systematic review and meta-analysis,” published in April 2021, the global pooled prevalence of subclinical mastitis (SCM) and clinical mastitis (CM) were 42% and 15%, respectively, during 2011–2019. The prevalence of mastitis is expected to increase due to the prolonged history of the disease in the dairy industry. The facts and data from across the world indicate the high prevalence of clinical mastitis, which triggers the demand for bovine diagnostics. Moreover, surveillance programs and good management systems introduced by governments in different countries support the bovine diagnostics market.
The bovine diagnostics market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in this region is mainly driven by the factors such as advancements in bovine diagnostics tools and technologies, increasing incidences of foot and mouth diseases and bTB, and a rise in bovine diagnostics to enhance the quality of food products containing bovine meat. Brazil counts for the largest share of the bovine diagnostic market in South & Central America. Brazil is the world’s leading livestock country, with the largest number of cattle grown. The growth of the world’s population and improvements in living standards boost the demand for meat across the world. Therefore, the demand for healthy meats results in the growth of the bovine diagnostics market in Brazil. Technological progress in diagnostics has enabled the diagnosis and phylogenetic analysis of bovine leukemia virus (BLV). The BLV infection in dairy cattle was evident in Maranhão, Northeastern Brazil, and for the first time in 2022, phylogenetic inferences showed genotype 6 in this region. This genotype is related to gene sequences previously identified in samples from central–western and southeastern Brazil. Thus, the development efforts for BLV and EBL diagnosis were initiated in 2022, which has fueled progress in leukemia treatment options for the cases of infections that are in an early stage. Enzootic bovine leukosis (EBL) is a chronic viral disease widely distributed in cattle herds and may take several years to manifest clinical signs. Thus, to prevent the epidemic in cattle, the diagnosis would allow veterinary health authorities and animal farmers to take preliminary actions.
The South & Central America bovine diagnostics market is segmented into product, disease type, end user, and country.
Based on product, the South & Central America bovine diagnostics market is segmented into immunoassay kits, PCR reagents & kits, hemagglutination inhibition (HI) assay, and other products. The immunoassay kits segment held the largest share of the South & Central America bovine diagnostics market in 2022.
Based on disease type, the South & Central America bovine diagnostics market is segmented into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and other disease types. The bovine mastitis segment held the largest share of the South & Central America bovine diagnostics market in 2022.
Based on end user, the South & Central America bovine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and other end-users. The veterinary hospitals segment held the largest share of the South & Central America bovine diagnostics market in 2022.
Based on country, the South & Central America bovine diagnostics market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America bovine diagnostics market in 2022.
Idexx Laboratories Inc, bioMerieux SA, Innovative Diagnostics SAS, Neogen Corp, and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America bovine diagnostics market.
Strategic insights for the South & Central America Bovine Diagnostics provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 114.01 Million |
Market Size by 2030 | US$ 179.57 Million |
Global CAGR (2022 - 2030) | 5.8% |
Historical Data | 2020-2021 |
Forecast period | 2023-2030 |
Segments Covered |
By Product
|
Regions and Countries Covered | South and Central America
|
Market leaders and key company profiles |
The geographic scope of the South & Central America Bovine Diagnostics refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The South & Central America Bovine Diagnostics Market is valued at US$ 114.01 Million in 2022, it is projected to reach US$ 179.57 Million by 2030.
As per our report South & Central America Bovine Diagnostics Market, the market size is valued at US$ 114.01 Million in 2022, projecting it to reach US$ 179.57 Million by 2030. This translates to a CAGR of approximately 5.8% during the forecast period.
The South & Central America Bovine Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Bovine Diagnostics Market report:
The South & Central America Bovine Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Bovine Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Bovine Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.